Mit
omycins are bi
oreductively activated DNA-alkylating agents. One member
of this family,mit
omycin C, is in clinical use as part
of c
ombinati
on therapy f
or certain s
olid tum
ors. The cyt
ot
oxicitydisplayed by mit
omycins is dependent
on their electr
ochemical p
otential which, in turn, is g
overned in partby the substituents
of the quin
one m
oiety. In this paper we describe studies
on the bi
ogenesis
of the quin
onemeth
oxy
group present in mit
omycins A and B. An engineered
Streptomyces lavendulae strain in whichthe
mmcR methyltransferase gene had been deleted failed t
o pr
oduce the three mit
omycins (A, B, and C)that are typically is
olated fr
om the wild type
organism. Analysis
of the culture extracts fr
om the
mmcR-deleti
on mutant strain revealed that tw
o new metab
olites, 7-demethylmit
omycin A and 7-demethylmit
omycinB, had accumulated instead. Pr
oducti
on
of mit
omycins A and C
or mit
omycin B was selectively rest
oredup
on supplementing the culture medium
of a
S. lavendulae strain unable t
o pr
oduce the key precurs
or3-amin
o-5-hydr
oxybenz
oate with either 7-demethylmit
omycin A
or 7-demethylmit
omycin B, respectively.MmcR methyltransferase
obtained by cl
oning and
overexpressi
on
of the c
orresp
onding
mmcR gene wassh
own t
o catalyze the 7-O-methylati
on
of b
oth C9
- and C9
-c
onfigured 7-hydr
oxymit
omycins
in vitro.This study pr
ovides direct evidence f
or the catalytic r
ole
of MmcR in f
ormati
on
of the 7-OMe
group that ischaracteristic
of mit
omycins A and B and dem
onstrates the prerequisite
of 7-O-methylati
on f
or the pr
oducti
on
of the clinical agent mit
omycin C.